Kirkpatrick B, Buchanan R W, Waltrip R W, Jauch D, Carpenter W T
Maryland Psychiatric Research Center, Baltimore 21228.
J Nerv Ment Dis. 1989 Jan;177(1):52-3. doi: 10.1097/00005053-198901000-00009.
In an open trial, nine drug-free schizophrenic patients received oral diazepam, 10 to 40 mg/day, for the treatment of early symptoms of relapse. Diazepam treatment led to a return of the patient's usual condition in seven of 11 episodes.
在一项开放性试验中，9名未服用药物的精神分裂症患者接受了口服地西泮治疗，剂量为每日10至40毫克，用于治疗复发的早期症状。在11次发作中，有7次地西泮治疗使患者恢复到了通常状态。
